Company Filing History:
Years Active: 2022
Title: Innovations by Viralkumar Rameshkumar Davra
Introduction
Viralkumar Rameshkumar Davra is an accomplished inventor based in Keasbey, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of fusion molecules for therapeutic applications. With a total of 2 patents, his work focuses on innovative methods for targeting diseases and conditions responsive to cytokine treatment.
Latest Patents
Davra's latest patents include groundbreaking inventions. The first patent is titled "Phosphatidylserine targeting fusion molecules and methods for their use." This invention involves fusion molecules of a cytokine or a portion thereof and a polypeptide that targets the fusion protein to phosphatidylserine. It also includes pharmaceutical compositions and methods for treating diseases or conditions responsive to cytokine treatment. The second patent is "Type I and type III interferon fusion molecules and methods for use thereof." This patent describes fusion molecules composed of type I and type III interferon proteins, along with pharmaceutical compositions and methods for inhibiting infections and treating various diseases.
Career Highlights
Viralkumar Rameshkumar Davra is affiliated with Rutgers, the State University of New Jersey, where he continues to advance his research and innovations. His work has garnered attention in the scientific community for its potential impact on therapeutic strategies.
Collaborations
Davra collaborates with esteemed colleagues, including Sergei V Kotenko and Raymond B Birge. These partnerships enhance the research and development of his innovative projects.
Conclusion
Viralkumar Rameshkumar Davra's contributions to biotechnology through his patents reflect his dedication to advancing medical science. His innovative approaches to targeting diseases demonstrate the potential for significant advancements in therapeutic treatments.